Previous | Next

Technology Transfer Revenues

Total Licensing Revenues

Total licensing revenues for OTT and campus offices rose 11% in FY96 to $70.3 million. Revenues include income from royalties, agreement issues and other fees, as well as expense reimbursements. This continues the steady upward trend reported over the past several years (Exhibit 10, below).

Royalties and Fee Income

The portion of licensing revenues from royalties and fees increased 10% in FY96 to $63.2 million. Exhibit 11 (below) indicates the income that OTT and the campus licensing offices contributed to this component of FY96 revenues.


Exhibit 10
TOTAL LICENSING REVENUES
(Millions)



Exhibit 11
Year Ended June 30, 1996
(Thousands)


OTT UCB UCLA UCSD TOTAL
Income from Royalties &Fees
(-) Payments to Joint Holders

Adjusted Gross Income*

$61,546 
(5,988)

$55,558 

$669 
(36)

$633

$944 
(5)

$939 

$45 
(0)

$45 

$63,204 
(6,029)

$57,175 

*Adjusted gross income takes into account royalty income received by the University that is passed on to other institutions who are joint owners of income-generating patents - see section on Payments to Joint Holders


Four-hundred thirty-seven (437) inventions generated royalty and fee income in FY96. Income from the top five royalty-generating inventions contributed $46.2 million in FY96 (Exhibit 12, below), accounting for 73% of total income. The top twenty-five royalty-generating technologies collectively accounted for $56.0 million or 89% of total income. One utility invention, Phosphorus Plant Fertilizer, appeared on the list for the first time in FY96. The UC invention portfolio is considered to be especially strong because it has a large number of diverse inventions generating earned-royalty income at a high level, as well as new inventions moving into the top group each year.

Expense Reimbursements

In addition to income from royalties and fees, the University received $7.1 million in expense reimbursements from its licensees in FY96. Reimbursements typically cover legal costs associated with patenting an invention. Reimbursements are a high priority objective during the license negotiation. Such reimbursements are considered to be part of the total licensing revenues, although they are treated as an offset to legal and other direct expenses for financial reporting purposes (see section on Legal Expenses).

Exhibit 12
UC TOP EARNING
COMMERCIALIZED INVENTIONS*
(Thousands)


(Invention, Campus, Year Disclosed) FY96

Hepatitis-B Vaccine (SF, 1979 and 1981)
Process for Splicing Genes (SF, 1974)
Human Growth Hormone (SF, 1977)
Nicotine Patch (LA, 1984)
Radiographic Media (SD, 1979)
Subtotal (Top Five Inventions)

Treatment-Intercranial Aneurysms (LA, 1989)
Strawberry-Oso Grande (DA, 1987)
Fluorescent Conjugated Probes (BK, 1981)
Feline Leukemia Virus Diagnostic (DA, 1980)
Lung Surfactant (SF, 1980)

Atomic Force Microscope (SB, 1989)
Feline AIDS Virus Diagnostic (DA, 1986)
Yeast Expression Vector (SF, 1982)
Strawberry-Chandler (DA, 1982)
X-Ray Transmission Scanning (SF, 1979)

Liposome Preservation Method (DA, 1984)
Strawberry-Camarosa (DA, 1992)
Strawberry-Pajaro (DA, 1978)
Magnetic Resonance Imaging (SF, 1976)
Strawberry-Selva (DA, 1982)

Walnut-Chandler (DA, 1977)
Phosphorus Plant Fertilizer (RV, 1990)
Marine Anti-inflammatory (SB & SD, 1984)
Canine Parvovirus Diagnostic (DA, 1982)
Table Grape-Redglobe (DA, 1979)

Total Income (Top 25 Inventions)
Total Income (All Inventions)

% of Total from Top 5 Inventions
% of Total from Top 25 Inventions

* List includes only commercialized
inventions with earned royalties.



$25,412
12,662
5,292
1,576
1,214
$46,156

1,196
970
785
748
694

614
536
533
517
507

479
382
309
271
260

241
228
215
211
176

$56,028
$63,204

73%
88%

Previous | Next